Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma

Journal of Dermatological Treatment

Volumn 22, Issue 4, 2011, Pages 233-238

  Suh, Kee Suck ^a   Sung, Jae Young ^b   Roh, Hyo Jin ^a   Jeon, Young Seung ^a   Kim, Yang Che ^b   Kim, Sang Tae ^a  

^a Kosin University   (South Korea)

^b Gowoonsesang Dr Yang Che Kim's Skin Clinic   (South Korea)

Author keywords

1064 nm Q switched Nd:YAG laser; Asian; Melasma

Indexed keywords

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KOREA; MELASMA AREA AND SEVERITY INDEX; NEODYMIUM LASER; PATIENT SATISFACTION; PHOTOGRAPHY; PRIORITY JOURNAL; RATING SCALE;

ADULT; FEMALE; HUMANS; LASERS, SOLID-STATE; MELANOSIS; MIDDLE AGED; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX;

EID: 79960443052     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546631003686051     Document Type: Article

References (15)

1. Pandya A, Berneburg M, Ortonne JP, Picardo M. Guidelines for clinical trials in melasma. Pigmentation Disorders Academy. Br J Dermatol. 2006;156(suppl 1):21-28. (Pubitemid 44809125)
2. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006;55:1048-1065. (Pubitemid 44716465)
3. Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228-237. (Pubitemid 34264392)
4. Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: A pilot study. Dermatol Surg. 1999;25:494-497. (Pubitemid 29279595)
5. Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: Split-face design. Dermatol Surg. 2003;29:59-64. (Pubitemid 36114731)
6. Yoshimura K, Sato K, Aiba-Kojima E, Matsumoto D, Machino C, Nagase T, et al. Repeated treatment protocols for melasma and acquired dermal melanocytosis. Dermatol Surg. 2006;32:365-371.
7. Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatol Clin. 2007;25:337-342. (Pubitemid 47088892)
8. Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium:yttrium-aluminum-garnet laser. A comparative study. J Dermatol Surg Oncol. 1994;20:795-800.
9. Goldberg DJ. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol. 1993;19:376-379. (Pubitemid 24175660)
10. Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: A pilot study. Dermatol Surg. 2005;31:1645-1650. (Pubitemid 43031166)
11. Naito SK. Fractional photothermolysis treatment for resistant melasma in Chinese females. J Cosmet Laser Ther. 2007;9:161-163. (Pubitemid 47347220)
12. Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-733. (Pubitemid 24182681)
13. Robertson AR. The CIE 1976 color-difference formulae. Color Res Appl. 1977;2:7-11.
14. Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: Two case reports. J Cosmet Laser Ther. 2008;10:167-173.
15. Goldberg DJ. Laser treatment of pigmented lesions. Dermatol Clin. 1997;15:397-407. (Pubitemid 27251158)